Baijin Life Science Holdings (HKG:1466) said it will delay the publication of its annual results for the year ended March 31, according to a late-Wednesday Hong Kong bourse filing.
Shares of the company were down about 1% in Thursday afternoon trade.
The company only assumed full operational control of the subsidiaries earlier this week and additional time is needed for its auditors and management to complete the audit, the company said.
It now expects to publish the results by July 25.
Baijin said it is not aware of any material issues affecting the audit or any disputes with its auditors. However, the delay will result in non-compliance with the Hong Kong listing rules.
If results are not published by June 30, trading in the company's shares will be suspended from July 2, the filing said.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。